...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Toinv that is correct, Don said that after Brad Cann has done his accounting wizardry that all shareholders of ZCC would have the same number of shares in the new operating company.

I assume you don't mean Zenith Epigenetics Ltd (Newco). It will have only 34.4 million shares total.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply